Objectives : The purpose of this study was to evaluate
the relationship of nonalcoholic fatty liver and
cardiovascular risk factors.
Methods : This study was conducted to investigate the
association of nonalcoholic fatty liver and cardiovascular
risk factors for adult men (n=2976) and women (n=2442)
who were over 19 years old, after excluding the HBsAg(+)
or anti-HCV(+) patients and the men and women with
increased alcohol intake (men: 40 g/week, women: 20
g/week).
Results : Compared with the normal liver subjects, the
nonalcoholic fatty liver subjects showed a significantly
increased frequency of abnormal systolic blood pressure
( 120 mmHg), fasting blood sugar ( 100 mg/dL), total
cholesterol ( 200 mg/dL), triglyceride ( 150 mg/dL), high
density lipoprotein cholesterol (<40 mg/dL), low density
lipoprotein cholesterol ( 130g m/dL) and abdominal
obesity in men, and all these measures were significantly
increased in the women except for abnormal HDL
cholesterol. After adjusting for the body mass index, age,
smoking, exercise and a nonalcoholic liver, the odds ratios
of an abnormal waist hip ratio were 1.35(95% Confidence
Interval=1.05-4.72) in the mild fatty liver, 1.61(1.19-2.18) in
the moderate fatty liver, 2.77(1.57-4.92) in the severe fatty
liver compared with a normal liver. The adjusted odds ratios
for abnormal fasting blood sugar were 1.26(1.03-1.53) in
the mild fatty liver, 1.62(1.27-2.06) in the moderate fatty
lliver and 1.77(1.12-2.78) in the severe fatty liver. The
adjusted odds ratios for abnormal triglyceride were
1.38(1.11-1.72) in the mild fatty liver, 1.73(0.33-2.24) in the
moderate fatty liver and 1.91(1.17-3.10) in the severe fatty
liver of men. Adjusted odds ratios for abnormal triglyceride
were 1.50(1.04-2.15) in mild, 1.71(1.07-2.68) in moderate,
1.81(0.69-4.38) in severe fatty liver of women.
Conclusions : The nonalcoholic fatty liver subjects had
more cardiovascular risk factors compared with the normal
liver subjects. Thus, prevention and treatment of the
nonalcoholic fatty liver is necessary by lifestyle
modifications such as restriction of alcohol intake, no
smoking, exercise and adequate eating habits.
Objectives : The purpose of this study was to evaluate
the relationship of nonalcoholic fatty liver and
cardiovascular risk factors.
Methods : This study was conducted to investigate the
association of nonalcoholic fatty liver and cardiovascular
risk factors for adult men (n=2976) and women (n=2442)
who were over 19 years old, after excluding the HBsAg(+)
or anti-HCV(+) patients and the men and women with
increased alcohol intake (men: 40 g/week, women: 20
g/week).
Results : Compared with the normal liver subjects, the
nonalcoholic fatty liver subjects showed a significantly
increased frequency of abnormal systolic blood pressure
( 120 mmHg), fasting blood sugar ( 100 mg/dL), total
cholesterol ( 200 mg/dL), triglyceride ( 150 mg/dL), high
density lipoprotein cholesterol (<40 mg/dL), low density
lipoprotein cholesterol ( 130g m/dL) and abdominal
obesity in men, and all these measures were significantly
increased in the women except for abnormal HDL
cholesterol. After adjusting for the body mass index, age,
smoking, exercise and a nonalcoholic liver, the odds ratios
of an abnormal waist hip ratio were 1.35(95% Confidence
Interval=1.05-4.72) in the mild fatty liver, 1.61(1.19-2.18) in
the moderate fatty liver, 2.77(1.57-4.92) in the severe fatty
liver compared with a normal liver. The adjusted odds ratios
for abnormal fasting blood sugar were 1.26(1.03-1.53) in
the mild fatty liver, 1.62(1.27-2.06) in the moderate fatty
lliver and 1.77(1.12-2.78) in the severe fatty liver. The
adjusted odds ratios for abnormal triglyceride were
1.38(1.11-1.72) in the mild fatty liver, 1.73(0.33-2.24) in the
moderate fatty liver and 1.91(1.17-3.10) in the severe fatty
liver of men. Adjusted odds ratios for abnormal triglyceride
were 1.50(1.04-2.15) in mild, 1.71(1.07-2.68) in moderate,
1.81(0.69-4.38) in severe fatty liver of women.
Conclusions : The nonalcoholic fatty liver subjects had
more cardiovascular risk factors compared with the normal
liver subjects. Thus, prevention and treatment of the
nonalcoholic fatty liver is necessary by lifestyle
modifications such as restriction of alcohol intake, no
smoking, exercise and adequate eating habits.